Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cannabidiol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 known ✓ | P21554 | 5/20 | 1.00 |
| ▸ | CNR2 | P34972 | 9/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 6/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 1.00 |
| ▸ | GPR55 | Q9Y2T6 | 3/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 2/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 1.00 |
| ▸ | MLNR | O43193 | 1/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | PDE9A | O76083 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | LDHA | P00338 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cannabidiol SCHEMBL16224872 | 1.00 | CNR2 (1.00) | CNR2OPRM1CNR1TRPV1GPR55 | |
| Cannabidiol SCHEMBL1644403 | 1.00 | CNR2 (1.00) | CNR2OPRM1CNR1TRPV1GPR55 | |
| Cannabidiol SCHEMBL122259 | 1.00 | CNR2 (1.00) | CNR2OPRM1CNR1TRPV1GPR55 | |
| Cannabidiol SCHEMBL23934764 | 1.00 | CNR2 (1.00) | CNR2OPRM1CNR1TRPV1GPR55 | |
| Cannabidiol SCHEMBL2229837 | 1.00 | CNR2 (1.00) | CNR2OPRM1CNR1TRPV1GPR55 | |
| Cannabidiol SCHEMBL23460334 | 1.00 | CNR2 (1.00) | CNR2OPRM1CNR1TRPV1GPR55 | |
| Cannabidiol SCHEMBL20201772 | 1.00 | CNR2 (1.00) | CNR2OPRM1CNR1TRPV1GPR55 | |
| Cannabidiol SCHEMBL2799993 | 1.00 | CNR2 (1.00) | CNR2OPRM1CNR1TRPV1GPR55 | |
| Cannabidiol SCHEMBL20930113 | 1.00 | CNR2 (1.00) | CNR2OPRM1CNR1TRPV1GPR55 | |
| Cannabidiol SCHEMBL16212393 | 1.00 | CNR2 (1.00) | CNR2OPRM1CNR1TRPV1GPR55 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 42419 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144805-A1 | CANNABIDIOL COMPOSITIONS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE AND NEUROLOGICAL DISORDERS | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2026-05-28 | — | — | US | claimed |
| US-20260145141-A1 | SEPARATION SYSTEMS FOR SEPARATING COMPONENTS OF AN EXTRACT SUSPENDED WITHIN A SOLVENT AND RELATED METHODS | Valor Equipment LLC, dba SciPhy Systems (US) | 2026-05-28 | — | — | US | claimed |
| EP-4412609-B1 | ALKOXYLATION OF CANNABIDIOL & OTHER CANNABINOIDS | INDORAMA VENTURES OXIDES LLC (US) | 2026-05-27 | — | — | EP | claimed |
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | Doane Technology Group LLC (US) | 2026-05-26 | — | — | US | claimed |
| US-12636294-B2 | Compositions and methods for the treatment or prevention of traumatic brain injury | Incannex Healthcare Limited (AU) | 2026-05-26 | — | — | US | claimed |
| WO-2026106946-A1 | NON-UV ANTIMICROBIAL LED CONTAINER SYSTEMS FOR FOOD, CANNABIS, AND HEALTHCARE APPLICATIONS | QUAZI FAZLE (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026103051-A1 | REAGENT COMBINATION, KIT AND DETECTION METHOD FOR DETECTING PLATELET ACTIVATION MARKER PAC-1 | 南京浦光生物科技有限公司 | 2026-05-21 | — | — | WO | claimed |
| WO-2026104804-A1 | CANNABIDIOL-BASED FORMULATION AND ITS USE FOR TREATING PAIN, INFLAMMATION | MRX Medical Limited (GB) | 2026-05-21 | — | — | WO | claimed |
| US-20260137708-A1 | TOPICAL FORMUATIONS AND INSTILLATES, KITS, AND METHODS FOR TREATING INTEGUMENTARY WOUNDS, AND USES THEREOF | VINSAN THERAPEUTICS INC (CA) | 2026-05-21 | — | — | US | claimed |
| WO-2026106917-A1 | EDIBLE TRANSMUCOSAL DRUG DELIVERY METHOD USING AN INTERMEDIATE CAPSULE AS A TEMPORARY VESSEL | BioPhysics Pharma, Inc. (US) | 2026-05-21 | — | — | WO | claimed |
| EP-1109533-A1 | PULMONARY DELIVERY OF LIPOSOME-ENCAPSULATED CANNABINOIDS | Hung, Orlando (CA) | 2001-06-27 | — | — | EP | claimed |
| EP-1071419-A1 | CANNABINOIDS AS ANTIOXIDANTS AND NEUROPROTECTANTS | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2001-01-31 | — | — | EP | claimed |
| EP-1071417-A1 | USE OF CANNABINOIDS AS ANTI-INFLAMMATORY AGENTS | THE MATHILDA AND TERENCE KENNEDY INSTITUTE OF RHEUMATOLOGY (GB) | 2001-01-31 | — | — | EP | claimed |
| WO-2001003690-A1 | NOVEL VASODILATOR CANNABINOID ANALOGS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2001-01-18 | — | — | WO | claimed |
| WO-2001003668-A1 | PULMONARY DELIVERY OF LIPOSOME-ENCAPSULATED CANNABINOIDS | HER MAJESTY THE QUEEN AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 2001-01-18 | — | — | WO | claimed |
| WO-2000056303-A2 | TREATMENT OF IMMUNE DISEASES | IMMUGEN PHARMACEUTICALS, INC. (US) | 2000-09-28 | — | — | WO | claimed |
| WO-1999053917-A1 | CANNABINOIDS AS ANTIOXIDANTS AND NEUROPROTECTANTS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-10-28 | — | — | WO | claimed |
| WO-1999052524-A1 | USE OF CANNABINOIDS AS ANTI-INFLAMMATORY AGENTS | THE MATHILDA & TERENCE KENNEDY INSTITUTE OF RHEUMATOLOGY (GB) | 1999-10-21 | — | — | WO | claimed |
| EP-0077393-A1 | NOVEL METHOD OF ADMINISTERING NARCOTIC ANTAGONISTS AND ANALGESICS AND NOVEL DOSAGE FORMS CONTAINING SAME | The University of Kentucky Research Foundation (US) | 1983-04-27 | — | — | EP | claimed |
| WO-1982003768-A1 | NOVEL METHOD OF ADMINISTERING NARCOTIC ANTAGONISTS AND ANALGESICS AND NOVEL DOSAGE FORMS CONTAINING SAME | UNIV KENTUCKY (US) | 1982-11-11 | — | — | WO | claimed |